The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome-editing technology belong to the Broad Institute of Harvard and MIT. The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome-editing technology belong to the Broad Institute of Harvard and MIT, dealing a blow to the University of California’s efforts to overturn those patents.

The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome-editing technology belong to the Broad Institute of Harvard and MIT. The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome-editing technology belong to the Broad Institute of Harvard and MIT, dealing a blow to the University of California’s efforts to overturn those patents.